PATENT CLAIM ANALYSIS

Application Number: 15893488
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "254090"]

Abstract:
Disclosed herein are compositions and methods for treating cancer, FLT3-AML, and CML.

Claim (Index 54):
A method of modulating activity of a FLT3-kinase, said method comprising contacting a FLT3-kinase with a compound having formula: wherein, L is a bond or substituted or unsubstituted alkylene; R 1  is \u2014Nr 2 R 3 ; R 2  and R 3  are independently substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, wherein R 2  and R 3  are optionally joined together to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and R 5  and R 6  are independently hydrogen or halogen; or pharmaceutically acceptable salts thereof, thereby modulating said activity of said FLT3-kinase.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15764724', '15796363', '15242318', '14689682', '15531245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7982793174868286
- 35 USC 102 Novelty (BERT): 0.531438427074782
- Combined Prediction Score: 0.7715952284456239
- Mean Citation Score: 359.688486
- Max Citation Score: 364.97186
- Similarity Product: 246.84693277655128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test